Innomedica is currently running
Influenza vaccine trial
The new flu vaccine trial will start in Innomedica in the fall of 2023.
The vaccine under study is a new technology. The purpose of the study is to evaluate the immune response (i.e. the body’s response) and safety of the new vaccine compared to the current flu vaccine.